The immune microenviroment in somatotropinomas: from biology to personalized and target therapy

Rev Endocr Metab Disord. 2023 Jan 20. doi: 10.1007/s11154-022-09782-1. Online ahead of print.ABSTRACTPituitary tumors are rare neoplasms, with a heterogeneous biological and clinical behavior, due to their clinical course, local invasive growth, resistance to conventional therapies and the risk of disease progression. Recent studies on tumor microenvironment (TME) provided new knowledge on the biology of these neoplasia, that may explain the different phenotypes of these tumors and suggest new biomarkers able to predict the prognosis and the treatment outcome. The identification of molecular markers that act as targets for biological therapies may open new perspectives in the medical treatments of aggressive pituitary tumors.In this paper, we will review data of TME and target therapies in somatotropinomas.PMID:36658300 | DOI:10.1007/s11154-022-09782-1
Source: ENDOCR REV - Category: Endocrinology Authors: Source Type: research